176
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Single Agent Epirubicin in Squamous Cell Cervical Cancer: A phase II trial

, , , , , , , , , & show all
Pages 325-327 | Received 10 Jan 1990, Accepted 08 Jun 1990, Published online: 08 Jul 2009

References

  • Hurteloup P, Cappelaere P, Armand J P, Mathe G. Phase II clinical evaluation of 4-epidoxorubicin. Cancer Treat Rep 1983; 67: 337–41
  • Berman M L, Ballon S C, Berek JS. Carcinoma of the uterine cervix. Cancer Treatment, C Haskell. WB Saunders., Philadelphia 1985; 438
  • Miller A B, Hoogstraten B, Staquet M. Reporting results of cancer treatment. Cancer 1981; 47: 207–14
  • Meanwell C A, Mould J J, Blackledge G, et al. Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 1986; 70: 727–30
  • Piver M S, Barlow J J, Xynos FP. Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina. Am J Obstet Gynecol 1978; 131: 311–3
  • Freedman R S, Herson J, Taylor J, Rutledge F. Single agent chemotherapy for recurrent carcinoma of the cervix. Cancer Clin Trials 1980; 3: 345–50
  • Malkasian G D, Decker D G, Green S J, et al. Treatment of recurrent and metastatic carcinoma of the cervix: Comparison of doxorubicin with a combination of vincristine and 5-fluorouracil. Gynecol Oncol 1981; 11: 235–9
  • Hickish T, Cuningham D, Haydock A, Coombes RC. Experience with intermediate dose (110–120 mg/m2) epirubicin. Cancer Chemother Pharmacol 1989; 24: 61–4
  • Wong L C, Choy D TK, Ngan H YS, et al. 4-epidoxorubicin in recurrent cervical cancer. Cancer 1989; 63: 1279–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.